Comparative efficacy of 20 mg of slow release nifedipine combined with either 25 or 50 mg of atenolol in patients with mild to moderately severe arterial hypertension;Vergleichbare antihypertensive Wirkung der Kombinationen von 20 mg retardiertem Nifedipin mit 25 bzw. 50 mg Atenolol. Eine Untersuchung uber die Behandlung von Patienten mit milder bis mittelschwerer arterieller Hypertonie

Praxis

Volumn 85, Issue 36, 1996, Pages 1081-1086

  Kraft, K ^a   Schiessl, S ^a   Vetter, H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

atenolol; mild hypertension; nifedipine; response rate; side effects

Indexed keywords

ATENOLOL; NIFEDIPINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0029839651     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Herxheimer A.: How much drug in the tablet? Lancet 337, 346-348, 1991.
2. Hansson L., Himmelmann A.: Combination therapy in the treatment of hypertension. Textbook of hypertension, Swales J. D., (ed.). Blackwell Scientific Publications, London, pp. 1142-1149, 1994.
3. Cruickshank J. M., Prichard B. N. C.: Beta-blockers. Textbook of hypertension, Swales J. D. (ed.). Blackwell Scientific Publications, London, pp. 1059-1088, 1994.
4. Swales J. D.: Calcium antagonists. Textbook of hypertension. Swales J. D. (ed.). Blackwell Scientific Publications, London, pp. 1111-1114, 1994.
5. Marshall A. J., Barritt D. W., Heaton S., Harry J. D.: Dose response for blood pressure and degree of cardiac β-blockade with atenolol. Postgrad. Med. J. 55, 537-540, 1979.
6. Leenen F. H. H., Davies R. A., Fourney A.: Role of cardiac β2-receptors in cardiac responses to exercise in cardiac transplant patients. Circulation 91, 685-690, 1995.
7. Materson B. J., Reda D. J., Cushman W. C., Massie B. M., Freis E. D., Kochar M. S., Hamburger R. J., Fye C., Lakshman R., Gottdiener J., Ramirez E. A., Henderson W. G.: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. New Engl. J. Med. 328, 914-921, 1993.
8. Sambol N. C., Sheiner L. B.: Population dose versus response of betaxolol and atenolol. A comparison of potency and variability. Clin. Pharmacol. Ther. 49, 24-31, 1991.
9. Brunner H. R., Menard J., Waeber B., Burnier M., Biolloz J., Nussberger J., Bellet M.: Treating the individual hypertensive patient. Consideration on dose, sequential monotherapy and drug combinations. J. Hypertens. 8, 3-11, 1990.
10. Zacharias F. J., Hayes P. J., Cruickshank J. M.: Atenolol in hypertension. A double blind comparison of the response to the different doses. Postgrad. Med. J. 53 (Suppl. 3), 114-115, 1977.
11. Christensen C. K., Lederballe P.O., Mikkelsen E.: Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor blocking drugs. Clin. Pharmacol. Ther. 32, 572-576, 1982.
12. Franz I. W., Wiewel D.: Antihypertenisve effects on blood pressure at rest and during exercise of calcium-agonists, beta-blockers, and their combination in hypertensive patients. J. Cardiovasc. Pharmacol. 6, 1037-1042, 1984.
13. Stanley N. N., Thirkettle J. L., Varma M. P. S., Larkin H., Heath I. D.: The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension. Eur. J. Clin. Pharmacol. 34, 543-546, 1988.
14. Kurz H.: β-Rezeptoren-Blocker. In: Ammon H. P. T. (Hrsg.). Arzneimittelneben- und Wechselwirkungen. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 176-194, 1991.
15. Rabkin S. W., Huff M. W., Newman C., Sim D., Carruthers S. G.: Lipids and lipoproteins during antihypertensive therapy. Comparison of doxazosin and atenolol in a randomized double-blind trial: the alpha-beta-Canada study. Hypertension 24, 241-248, 1994.